There they go again, keeping us informed.
Good to hear about the meeting on the 18th for approval of cohort 3. This should see dosing before the end of the month and a quick recruitment given the transition of patients.
worth giving the announcement a thumbs up.
Ann: Progress update on Phase 1/2 MND interim analysis, page-4
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.32M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.5¢ | $34.16K | 182.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 915557 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 214650 | 3 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |